EPISODE · Aug 8, 2012 · 16 MIN
Statin Safety Considerations
from Lipid Luminations
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Dean A. Bramlet, MD, FACC, FACP Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin toxicity and the overall effectiveness of statins. Dr. Bramlett is the medical director of the Heart and Lipid Institute of Florida in St. Petersburg, Florida; and, assistant consultant professor at Duke University. Brought to you by:
What this episode covers
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Dean A. Bramlet, MD, FACC, FACP Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin toxicity and the overall effectiveness of statins. Dr. Bramlett is the medical director of the Heart and Lipid Institute of Florida in St. Petersburg, Florida; and, assistant consultant professor at Duke University. Brought to you by:
NOW PLAYING
Statin Safety Considerations
No transcript for this episode yet
Similar Episodes
Jun 1, 2026 ·21m
Apr 29, 2026 ·11m
Apr 16, 2026 ·27m